0.5 mL of the mid dose VAX-31

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-31 in Healthy InfantsNCT06720038PCVXPhase 2Active not recruiting2027-12Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.